KR930016436A - 4, 13-디옥사바이사이클로[8.2.1]트리데세논유도체와 그의 제조방법, 그의 제조를 위한 중간체 및 이화합물이 함유된 약학조성물 - Google Patents
4, 13-디옥사바이사이클로[8.2.1]트리데세논유도체와 그의 제조방법, 그의 제조를 위한 중간체 및 이화합물이 함유된 약학조성물 Download PDFInfo
- Publication number
- KR930016436A KR930016436A KR1019920026335A KR920026335A KR930016436A KR 930016436 A KR930016436 A KR 930016436A KR 1019920026335 A KR1019920026335 A KR 1019920026335A KR 920026335 A KR920026335 A KR 920026335A KR 930016436 A KR930016436 A KR 930016436A
- Authority
- KR
- South Korea
- Prior art keywords
- dioxabicyclo
- formula
- preparation
- methyl group
- structural formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
본 발명은 위장에 효과적인 모티린-길항 특성을 지닌 환형으로 축합된 N-데메틸-N-이소프로-필-에리스로마이신 A유도체 및 이의 제조방법에 관하여 기술되어 있다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (5)
- 구조식(Ⅰ)를 표시하는 [2R, 3R(2R′,3R′), 6R, 7S, 8S, 9R, 10R]-3-(2′,3′-디하이드록시펜트-2′-일)-2,6,8,10,12-펜타메틸-4,13-디옥사바이사이클로[8,2,1]트리데-12-센-5-온유도체와 안정성이 있고 생리적인 적응성이 양호한 그의 산부가염들.상기식(Ⅰ)에서 R′은 메틸 또는 수소를 나타낸다.
- 제1항에 있어서, R1이 메틸기인 것을 특징으로 하는 화합물.
- 약학적 유효량의 제1항에 따른 화합물과 통상의 약제학적 보조제 및/또는 담체가 함유된 약제학적 조성물.
- 구조식(Ⅱ)로 표시되는 [2R, 3R(2R′,3R′), 6R, 7S, 8S, 9R, 10R]-3-(2′,3′-디하이드록시펜트-2′-일)-2,6,8,10,12-펜타메틸-4,13-디옥사바이사이클로[8,2,1]트리데-12-센-5-온유도체에 하나의 이소프로필기를 도입시키고 필요하나 경우 R1이 메틸기인 구조식(Ⅰ)의 화합물에서 메틸기 R1를 제거하거나, 메틸기 R1이 수소인 구조식(Ⅰ)의 화합물에 메틸기 R1도입하며, 필요한 경우 구조식(Ⅰ)의 유리 화합물을 그의 안정된 산부가염 형태로 전환하거나 산부가염 형태를 구조식(Ⅰ)의 유리 화합물로 전환시키는 것을 특징으로 하는 구조식(Ⅰ)로 표시되는 [2R, 3R(2R′,3R′), 6R, 7S, 8S, 9R, 10R]-3-(2′,3′-디하이드록시펜트-2′-일)-2,6,8,10,12-펜타메틸-4,13-디옥사바이사이클로[8,2,1]트리데-12-센-5-온유도체와 안정성이 있고 생리적인 적응성이 양호한 그의 산부가염들을 제조하는 방법.상기식(Ⅰ), (Ⅱ)에서 R1은 메틸 또는 수소를 나타낸다.
- 구조식(Ⅱ)로 표시되는 [2R, 3R(2R′,3R′), 6R, 7S, 8S, 9R, 10R]-3-(2′,3′-디하이드록시펜트-2′-일)-2,6,8,10,12-펜타메틸-4,13-디옥사바이사이클로[8,2,1]트리데-12-센-5-온유도체.상기식(Ⅱ)에서 R1은 메틸 또는 수소를 나타낸다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4200145.5 | 1992-01-07 | ||
DE4200145A DE4200145A1 (de) | 1992-01-07 | 1992-01-07 | 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
KR930016436A true KR930016436A (ko) | 1993-08-26 |
KR100273937B1 KR100273937B1 (ko) | 2000-12-15 |
Family
ID=6449136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920026335A KR100273937B1 (ko) | 1992-01-07 | 1992-12-28 | 4,13-디옥사바이사이클로[8.2.1]트리데세논 유도체와 그의 제조방법 및 이 화합물이 함유된 약학조성물 |
Country Status (28)
Country | Link |
---|---|
US (1) | US5418224A (ko) |
EP (1) | EP0550895B1 (ko) |
JP (1) | JP3300084B2 (ko) |
KR (1) | KR100273937B1 (ko) |
CN (1) | CN1033646C (ko) |
AT (1) | ATE155478T1 (ko) |
AU (1) | AU667699B2 (ko) |
CA (1) | CA2086811C (ko) |
CZ (1) | CZ281773B6 (ko) |
DE (2) | DE4200145A1 (ko) |
DK (1) | DK0550895T3 (ko) |
DZ (1) | DZ1652A1 (ko) |
ES (1) | ES2104808T3 (ko) |
FI (1) | FI106862B (ko) |
GR (1) | GR3024859T3 (ko) |
HK (1) | HK1014003A1 (ko) |
HU (2) | HU212272B (ko) |
IL (1) | IL104158A (ko) |
LT (1) | LT3015B (ko) |
LV (1) | LV10458B (ko) |
MX (1) | MX9300045A (ko) |
NO (1) | NO179586C (ko) |
PH (1) | PH30098A (ko) |
RU (1) | RU2107070C1 (ko) |
SK (1) | SK279251B6 (ko) |
TW (1) | TW238308B (ko) |
UA (1) | UA29393C2 (ko) |
ZA (1) | ZA9339B (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69637097T2 (de) * | 1995-10-13 | 2007-09-20 | Neurosearch A/S | 8-Azabicyclo(3.2.1)Oct-2-en-Derivate, deren Herstellung und Anwendung |
EP0884322A4 (en) * | 1996-03-01 | 2002-04-24 | Takeda Chemical Industries Ltd | PROCESS FOR THE PREPARATION OF ERYTHROMYCIN DERIVATIVES |
US6077943A (en) * | 1996-03-01 | 2000-06-20 | Takeda Chemical Industries, Ltd. | Method of producing erythromycin derivative |
DE19644195A1 (de) * | 1996-10-24 | 1998-04-30 | Solvay Pharm Gmbh | 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19805822B4 (de) * | 1998-02-13 | 2009-02-05 | Solvay Pharmaceuticals Gmbh | 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US6165985A (en) * | 1998-02-13 | 2000-12-26 | Solvay Pharmaceuticals Gmbh | 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
CA2386828C (en) * | 2000-08-17 | 2006-01-24 | The Kitasato Institute | Novel pseudoerythromycin derivatives |
DE50204789D1 (de) * | 2001-05-10 | 2005-12-08 | Solvay Pharm Gmbh | Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US20040067896A1 (en) * | 2002-07-25 | 2004-04-08 | The Kitasato Institute | Novel pseudoerythromycin derivatives |
JP4928261B2 (ja) | 2003-06-18 | 2012-05-09 | トランザイム・ファーマ・インコーポレイテッド | モチリン受容体の大環状拮抗薬 |
US7582611B2 (en) * | 2005-05-24 | 2009-09-01 | Pfizer Inc. | Motilide compounds |
BRPI0619556A2 (pt) * | 2005-12-08 | 2011-10-04 | Pfizer | processo para desmetilação de grupo 3' -dimetil amino de compostos eritromicina |
EP2431380A3 (en) | 2006-09-11 | 2013-07-03 | Tranzyme Pharma, Inc. | Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
BRPI0719565A2 (pt) * | 2006-12-05 | 2013-12-10 | Pfizer | Polimorfos de motilídeo |
US20080287371A1 (en) * | 2007-05-17 | 2008-11-20 | Tranzyme Pharma Inc. | Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex |
EP2979702A4 (en) * | 2013-03-25 | 2016-11-16 | Zeria Pharm Co Ltd | POSTPRANDIAL GASTROKINETIC AGENT |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3725385A (en) | 1970-11-02 | 1973-04-03 | Abbott Lab | Process for the demethylation of 3-amino macrolides |
CA1321581C (en) * | 1987-05-26 | 1993-08-24 | Herbert A. Kirst | Ring-contracted macrolides |
US5106961A (en) * | 1987-05-26 | 1992-04-21 | Eli Lilly And Company | Erythromycin ring-contracted derivatives |
US4920102A (en) * | 1988-04-18 | 1990-04-24 | Eli Lilly And Company | Method for treating gastrointestinal disorders |
-
1992
- 1992-01-07 DE DE4200145A patent/DE4200145A1/de not_active Withdrawn
- 1992-11-18 SK SK3414-92A patent/SK279251B6/sk unknown
- 1992-11-18 CZ CS923414A patent/CZ281773B6/cs not_active IP Right Cessation
- 1992-12-13 DZ DZ920162A patent/DZ1652A1/fr active
- 1992-12-18 PH PH45475A patent/PH30098A/en unknown
- 1992-12-18 IL IL104158A patent/IL104158A/xx not_active IP Right Cessation
- 1992-12-21 HU HU9204076A patent/HU212272B/hu not_active IP Right Cessation
- 1992-12-22 LT LTIP187A patent/LT3015B/lt not_active IP Right Cessation
- 1992-12-23 US US07/996,083 patent/US5418224A/en not_active Expired - Lifetime
- 1992-12-24 DK DK92122011.7T patent/DK0550895T3/da active
- 1992-12-24 DE DE59208710T patent/DE59208710D1/de not_active Expired - Fee Related
- 1992-12-24 ES ES92122011T patent/ES2104808T3/es not_active Expired - Lifetime
- 1992-12-24 AT AT92122011T patent/ATE155478T1/de not_active IP Right Cessation
- 1992-12-24 EP EP92122011A patent/EP0550895B1/de not_active Expired - Lifetime
- 1992-12-28 KR KR1019920026335A patent/KR100273937B1/ko not_active IP Right Cessation
- 1992-12-30 RU RU92016224A patent/RU2107070C1/ru not_active IP Right Cessation
-
1993
- 1993-01-05 ZA ZA9339A patent/ZA9339B/xx unknown
- 1993-01-06 LV LVP-93-01A patent/LV10458B/lv unknown
- 1993-01-06 AU AU31036/93A patent/AU667699B2/en not_active Ceased
- 1993-01-06 CA CA002086811A patent/CA2086811C/en not_active Expired - Fee Related
- 1993-01-06 NO NO930029A patent/NO179586C/no unknown
- 1993-01-06 JP JP00055793A patent/JP3300084B2/ja not_active Expired - Fee Related
- 1993-01-06 CN CN93100166A patent/CN1033646C/zh not_active Expired - Fee Related
- 1993-01-07 MX MX9300045A patent/MX9300045A/es not_active IP Right Cessation
- 1993-01-07 FI FI930051A patent/FI106862B/fi active
- 1993-03-25 TW TW082102267A patent/TW238308B/zh active
- 1993-04-22 UA UA93002699A patent/UA29393C2/uk unknown
-
1994
- 1994-09-30 HU HU94P/P00031P patent/HU210216A9/hu unknown
-
1997
- 1997-09-24 GR GR970402503T patent/GR3024859T3/el unknown
-
1998
- 1998-12-17 HK HK98113965A patent/HK1014003A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930016436A (ko) | 4, 13-디옥사바이사이클로[8.2.1]트리데세논유도체와 그의 제조방법, 그의 제조를 위한 중간체 및 이화합물이 함유된 약학조성물 | |
KR950017957A (ko) | 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체 | |
KR880008986A (ko) | D 계열 프로스타글란딘, 및 그를 함유하는 정신안정제와 최면제 | |
KR890011592A (ko) | 기관내 허혈병의 치료용 조성물 | |
KR920021517A (ko) | 중축 신경계에 활성인 신규의 3-아미노피리다진 유도체, 그의 제조방법 및 이들의 존재하는 약제학적 조성물 | |
KR930703236A (ko) | 리그난 유사체. 이의 제조방법 및 이를 함유한 항지혈증제 | |
KR900016178A (ko) | 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물 | |
DK601683D0 (da) | Dialkylaminoalkoxybenzylalkoholderivater | |
KR900003177A (ko) | 테트라시클릭계 우울증 치료제 | |
KR930006003A (ko) | 이미다졸릴메틸-피리딘류 화합물 | |
AU579665B2 (en) | 2-pyridine-thiol derivatives | |
KR850001903A (ko) | 2,6-이중치환-1,4-디하이드로피리딘 유도체의 제조방법과 이것을 포함하는 약학적 조성물 | |
KR920002594A (ko) | 5-이소티아졸아민 유도체 | |
RU95107147A (ru) | Производные циклогексанкарбоновой кислоты, смесь их изомеров или отдельные изомеры и физиологически переносимые соли и фармацевтическая композиция с тормозящей ферментный комплекс глюкоза-6-фосфатазы печени активностью | |
KR920700210A (ko) | 신규 이미다졸 유도체, 그의 제법 및 그의 의약용도 | |
SE8804696L (sv) | Dioxazocin- derivat, deras framstaellning och beredningar innehaallande desamma | |
KR890009876A (ko) | 9-아실아미노- 테트라히드로아크리딘 유도체 및 그 유도체를 활성성분으로 포함하는 기억력 촉진제 | |
KR920002564A (ko) | N-알킬 티아졸리딘 유도체 | |
KR910014369A (ko) | 이미다졸릴 프로필 구아니딘 유도체와 그 제조방법 및 이를 함유하는 약학적 조성물 | |
KR890005087A (ko) | 4- 피페리딘 카르복사미드 유도체 | |
KR920002613A (ko) | 이환성 함유 황화합물 | |
KR890003758A (ko) | 피롤로[2,1-a]이소피롤린 유도체, 그들의 제조방법, 그들을 함유하는 조성물 및 그들의 이용 | |
KR890006656A (ko) | 약물동력학적으로 개선된 세팔로스포린 유도체, 그의 제조방법 그를 함유하는 약제학적 조성물 및 합성 중간체 | |
SE8405332L (sv) | 2h-azeto (2,1-a)-isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem | |
KR950000638A (ko) | 3, 4-디히드록시칼콘 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20080901 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |